Hammurabi, Vertices lead on Cadila acquisition of stake in Windlass for 155 croreNovember 5 2018
Drug firm Cadila Healthcare has acquired 51% stake in Windlass Healthcare for Rs. 155.55 crore.
Hammurabi & Solomon represented Cadila Healthcare, with a team led by Partner Pathik Arora, who now has joined Senvion as the India GC, and counsel Gaurav Adusumalli.
Vertices Partners acted for Windlass Healthcare with a team led by Managing Partner Vinayak Burman.
The acquisition, all in cash, will be completed by the end of September 2018.
With a premium account you get:
- One year of unrestrcited access to previous interviews, columns and articles
- One year access to all archival material
- Access to all Bar & Bench reports